In contrast to U0126, MK2206 (3 μM), a selective AKT1/2/3-inhibitor, failed to re-sensitize GIST-T1R cells to IM (Figure 3C,D). This evidence concerns the gene AKT1 and gastrointestinal stromal tumor.